Two Sigma Investments’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.67M Sell
7,600
-6,400
-46% -$2.28M ﹤0.01% 2544
2025
Q4
$4.58M Buy
14,000
+13,000
+1,300% +$4.12M 0.01% 1792
2025
Q3
$282K Buy
+1,000
New +$290K ﹤0.01% 3241
2022
Q1
Sell
-35,300
Closed -$7.94M 2638
2021
Q4
$7.94M Sell
35,300
-71,700
-67% -$15.1M 0.02% 918
2021
Q3
$22.8M Buy
107,000
+80,900
+310% +$18.6M 0.05% 424
2021
Q2
$6.36M Buy
26,100
+14,000
+116% +$3.44M 0.01% 1057
2021
Q1
$3.01M Sell
12,100
-6,700
-36% -$1.6M 0.01% 1390
2020
Q4
$4.32M Buy
18,800
+2,100
+13% +$484K 0.01% 1020
2020
Q3
$4.24M Buy
16,700
+9,400
+129% +$2.33M 0.02% 877
2020
Q2
$1.72M Sell
7,300
-10,400
-59% -$2.37M 0.01% 1174
2020
Q1
$3.59M Sell
17,700
-10,600
-37% -$2.32M 0.03% 656
2019
Q4
$6.82M Sell
28,300
-800
-3% -$176K 0.02% 779
2019
Q3
$5.63M Sell
29,100
-25,000
-46% -$4.8M 0.02% 801
2019
Q2
$9.97M Buy
54,100
+49,100
+982% +$8.79M 0.03% 603
2019
Q1
$950K Buy
5,000
+2,000
+67% +$382K ﹤0.01% 1863
2018
Q4
$584K Sell
3,000
-25,900
-90% -$5.05M ﹤0.01% 1997
2018
Q3
$5.99M Sell
28,900
-207,700
-88% -$40.9M 0.02% 870
2018
Q2
$43.7M Buy
236,600
+222,600
+1,590% +$39.4M 0.13% 202
2018
Q1
$2.39M Buy
14,000
+3,000
+27% +$551K 0.01% 1400
2017
Q4
$1.91M Buy
11,000
+3,000
+38% +$531K 0.01% 1505
2017
Q3
$1.49M Hold
8,000
0.01% 1475
2017
Q2
$1.38M Sell
8,000
-9,900
-55% -$1.61M 0.01% 1690
2017
Q1
$2.94M Buy
17,900
+10,900
+156% +$1.81M 0.01% 1215
2016
Q4
$1.02M Sell
7,000
-4,000
-36% -$602K ﹤0.01% 1996
2016
Q3
$1.83M Buy
11,000
+1,000
+10% +$169K 0.01% 1525
2016
Q2
$1.52M Buy
10,000
+1,000
+11% +$155K 0.01% 1452
2016
Q1
$1.35M Sell
9,000
-32,000
-78% -$4.75M 0.01% 1424
2015
Q4
$6.66M Buy
41,000
+39,000
+1,950% +$6.13M 0.03% 574
2015
Q3
$277K Sell
2,000
-10,000
-83% -$1.58M ﹤0.01% 1821
2015
Q2
$1.84M Buy
12,000
+5,000
+71% +$801K 0.01% 1250
2015
Q1
$1.12M Buy
+7,000
New +$1.1M 0.01% 1508

Other funds holding AMGN

Two Sigma Investments's AMGN Position: Q1 2026 in Review

Two Sigma Investments reduced its Amgen (AMGN) stake by 90% in Q1 2026, selling an estimated $224M and leaving 71,680 shares worth $25.2M. The position accounts for 0.02% of the portfolio, ranked #813.

Two Sigma Investments first reported a position in AMGN in Q4 2013 and has held it in 46 quarters since. The position peaked at $253M in Q1 2022. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Two Sigma Investments held 71,680 shares of Amgen worth $25.2M as of Q1 2026.
  • Two Sigma Investments sold 628,708 Amgen shares in Q1 2026, an estimated $224M.
  • Amgen made up 0.02% of Two Sigma Investments's portfolio in Q1 2026, its #813 holding.
  • Two Sigma Investments first reported a position in Amgen in Q4 2013 and has held it in 46 quarters since.
  • Two Sigma Investments's Amgen position peaked at $253M in Q1 2022.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.